Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors

Journal of Clinical Oncology

Volumn 20, Issue 18, 2002, Pages 3898-3905

  Singer, Samuel ^a   Rubin, Brian P ^a   Lux, Marcia L ^a   Chen, Chang Jie ^a   Demetri, George D ^a   Fletcher, Christopher D M ^a   Fletcher, Jonathan A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; STEM CELL FACTOR RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DNA TEMPLATE; EXON; FEMALE; FOLLOW UP; FROZEN SECTION; GASTROINTESTINAL TUMOR; GENE DELETION; GENE INSERTION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MISSENSE MUTATION; MITOSIS RATE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SPINDLE CELL; STROMA; SURVIVAL TIME; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DNA, NEOPLASM; EXONS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MITOTIC INDEX; MUTATION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; SEQUENCE DELETION; STROMAL CELLS; SURVIVAL RATE;

EID: 0037106370     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.03.095     Document Type: Article

References (37)

1. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal)
2. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal
3. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
4. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity
5. Developmental origin and Kit-dependent development of the interstitial cells of cajal in the mammalian small intestine
6. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype
7. Diagnosis of gastrointestinal stromal tumors: A consensus approach
8. From white spots to stem cells: The role of the Kit receptor in mammalian development
9. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
10. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
11. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
12. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
13. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
14. Gastrointestinal stromal tumours: Correlation of immunophenotype with clinicopathological features
15. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors
16. Nonparametric estimation from incomplete observations
17. Asymptomatically efficient rank invariant test procedures
18. Regression models and life tables
19. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT)
20. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival
21. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site
22. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors
23. A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract
24. Gastrointestinal stromal tumors: DNA flow-cytometric study of 58 patients with at least five years of follow-up
25. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors
26. Gastrointestinal stromal tumors: Analysis of clinical and pathologic factors
27. Predicting metastatic risk of gastrointestinal stromal tumors: Role of cell proliferation and cell cycle regulatory proteins
28. Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariate clinicopathologic study
29. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma
30. EWS-FLII fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma
31. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia
32. DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors
33. DNA copy number changes in gastrointestinal stromal tumors: A distinct genetic entity
34. DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance
35. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications
36. Evaluation of the safety and efficacy of an oral molecularly targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors expressing c-kit